Participants 37 117 3
acute coronary syndromes in Canada: a long-term analysis based on the CURE trial
Participants 575 787 7
reducing cardiovascular events in patients with acute coronary syndromes and, in addition, patients undergoing percutaneous coronary intervention in the Percutaneous Coronary Intervention in CURE (PCI-CURE) trial
Participants 854 881 3
Canadian health care system
Participants 1541 1692 7
The probability of clopidogrel resulting in cost per life-year gained of less than $20,000 was 0.975 for CURE patients and 0.904 for PCI-CURE patients.
